|
US2017260134A1
|
|
Ceramide Analogs
|
|
US2017258842A1
|
|
Methods and Compositions for Treating Ovarian Failure
|
|
US2017216355A1
|
|
Methods and Compositions for Enhancing T Cell Function and Survival
|
|
US2017088905A1
|
|
Compositions and methods for the detection or treatment of uterine leiomyosarcoma
|
|
US2017087125A1
|
|
Flavonoid compositions for the treatment of cancer
|
|
WO2017004167A1
|
|
Methods and compositions for treating cancer
|
|
WO2016109665A1
|
|
Compositions and methods for immune therapy
|
|
EP3226977A2
|
|
Glass composites for tissue augmentation, biomedical and cosmetic applications
|
|
US2016022614A1
|
|
Compositions and methods for treating cancer
|
|
US2015343028A1
|
|
Methods of modulating immune responses by modifying Akt3 bioactivity
|
|
US2015093759A1
|
|
Compositions and methods for detecting nitration of PKG-1α and methods of use thereof
|
|
US2015080288A1
|
|
Nitration shielding peptides and methods of use thereof
|
|
US2014314715A1
|
|
Compositions and methods for diagnosing and treating Sjogren's Syndrome
|
|
US2014243268A1
|
|
Methods of using ERBB2 conjugate peptides
|
